SNCAIP Antikörper (C-Term)

Produktnummer ABIN5532212

Produktdetails anti-SNCAIP Antikörper

Target: SNCAIP (Synuclein, alpha Interacting Protein (SNCAIP))

Bindungsspezifität: AA 593-622, C-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SNCAIP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Immunogen: This Synphilin-1 (SNCAIP) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 593-622 amino acids from the C-terminal region of human Synphilin-1 (SNCAIP).

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: For WB starting dilution is: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 2 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu SNCAIP

Target: SNCAIP (Synuclein, alpha Interacting Protein (SNCAIP))

Andere Bezeichnung: Synphilin-1 (SNCAIP Produkte)

Synonyme: sncaip antikoerper, MGC88953 antikoerper, SNCAIP antikoerper, LOC100221074 antikoerper, SYPH1 antikoerper, Sph1 antikoerper, Syph1 antikoerper, 2810407O15Rik antikoerper, 4933427B05Rik antikoerper, BB104594 antikoerper, synuclein alpha interacting protein antikoerper, synuclein, alpha interacting protein antikoerper, synuclein, alpha interacting protein (synphilin) antikoerper, SNCAIP antikoerper, sncaip antikoerper, Sncaip antikoerper

Hintergrund: Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. Synuclein alpha interacting protein (Synphilin-1) contains several protein-protein interaction domains and interacts with alpha synuclein in neurons. Mutations of SNCAIP have been linked to Parkinson disease. The amino acid sequence of synphilin-1 shows extensive homology with its human counterpart, especially in regions containing ankyrin-like motifs and the coiled-coil domain. Expression of mouse synphilin-1 in tissues is similar to its human counterpart. Synphilin-1 has an important role in the formation of aggregates and cytotoxicity in Parkinson disease and that Dorfin may be involved in the pathogenic process by ubiquitylation of synphilin-1. Role of synphilin-1 in synaptic function and protein degradation and in the molecular mechanisms leading to neurodegeneration in Parkinson disease

Molekulargewicht: 100 kDa

Gen-ID: 9627

UniProt: Q9Y6H5